178 related articles for article (PubMed ID: 9314833)
1. Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels.
Welling A; Ludwig A; Zimmer S; Klugbauer N; Flockerzi V; Hofmann F
Circ Res; 1997 Oct; 81(4):526-32. PubMed ID: 9314833
[TBL] [Abstract][Full Text] [Related]
2. Distribution, splicing and glucocorticoid-induced expression of cardiac alpha 1C and alpha 1D voltage-gated Ca2+ channel mRNAs.
Takimoto K; Li D; Nerbonne JM; Levitan ES
J Mol Cell Cardiol; 1997 Nov; 29(11):3035-42. PubMed ID: 9405178
[TBL] [Abstract][Full Text] [Related]
3. Two stable cell lines for screening of calcium channel blockers.
Seisenberger C; Welling A; Schuster A; Hofmann F
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):662-9. PubMed ID: 9053739
[TBL] [Abstract][Full Text] [Related]
4. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.
Hu H; Marban E
Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of cardiac Ca2+ channel pharmacology. Subunit requirement for the high affinity and allosteric regulation of dihydropyridine binding.
Wei X; Pan S; Lang W; Kim H; Schneider T; Perez-Reyes E; Birnbaumer L
J Biol Chem; 1995 Nov; 270(45):27106-11. PubMed ID: 7592963
[TBL] [Abstract][Full Text] [Related]
6. Molecular pharmacology of UK-118, 434-05, a permanently charged amlodipine analog.
Heath B; Xia J; Kass RS
Int J Cardiol; 1997 Dec; 62 Suppl 2():S47-54. PubMed ID: 9488195
[TBL] [Abstract][Full Text] [Related]
7. The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits.
Morel N; Buryi V; Feron O; Gomez JP; Christen MO; Godfraind T
Br J Pharmacol; 1998 Nov; 125(5):1005-12. PubMed ID: 9846638
[TBL] [Abstract][Full Text] [Related]
8. Different voltage-dependent inhibition by dihydropyridines of human Ca2+ channel splice variants.
Soldatov NM; Bouron A; Reuter H
J Biol Chem; 1995 May; 270(18):10540-3. PubMed ID: 7737988
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
10. Multiple transcripts of Ca2+ channel alpha1-subunits and a novel spliced variant of the alpha1C-subunit in rat ductus arteriosus.
Yokoyama U; Minamisawa S; Adachi-Akahane S; Akaike T; Naguro I; Funakoshi K; Iwamoto M; Nakagome M; Uemura N; Hori H; Yokota S; Ishikawa Y
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1660-70. PubMed ID: 16272207
[TBL] [Abstract][Full Text] [Related]
11. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells.
Gollasch M; Haase H; Ried C; Lindschau C; Morano I; Luft FC; Haller H
FASEB J; 1998 May; 12(7):593-601. PubMed ID: 9576486
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels.
Kanda S; Adachi-Akahane S; Nagao T
Eur J Pharmacol; 1998 Oct; 358(3):277-87. PubMed ID: 9822895
[TBL] [Abstract][Full Text] [Related]
13. C-terminal alternative splicing of CaV1.3 channels distinctively modulates their dihydropyridine sensitivity.
Huang H; Yu D; Soong TW
Mol Pharmacol; 2013 Oct; 84(4):643-53. PubMed ID: 23924992
[TBL] [Abstract][Full Text] [Related]
14. Identification of structural elements of the testis-specific voltage dependent calcium channel that potentially regulate its biophysical properties.
Goodwin LO; Leeds NB; Guzowski D; Hurley IR; Pergolizzi RG; Benoff S
Mol Hum Reprod; 1999 Apr; 5(4):311-22. PubMed ID: 10321802
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of exons in the alpha1 subunit of the rat testis L-type voltage-dependent calcium channel generates germ line-specific dihydropyridine binding sites.
Goodwin LO; Leeds NB; Hurley I; Cooper GW; Pergolizzi RG; Benoff S
Mol Hum Reprod; 1998 Mar; 4(3):215-26. PubMed ID: 9570267
[TBL] [Abstract][Full Text] [Related]
16. Modulation by dihydropyridine-type calcium channel antagonists of cytokine-inducible gene expression in vascular smooth muscle cells.
Cattaruzza M; Wachter R; Wagner AH; Hecker M
Br J Pharmacol; 2000 Mar; 129(6):1155-62. PubMed ID: 10725264
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of elgodipine and nisoldipine on the contractile responses of various isolated blood vessels.
Chulia T; Gonzalez P; Del Rio M; Tejerina T
Eur J Pharmacol; 1995 Oct; 285(2):115-22. PubMed ID: 8566128
[TBL] [Abstract][Full Text] [Related]
18. The long-term inhibitory effect of a Ca2+ channel blocker, nisoldipine, on cytosolic Ca2+ and contraction in vascular smooth muscle.
Kim BK; Mitsui M; Karaki H
Eur J Pharmacol; 1992 Nov; 223(2-3):157-62. PubMed ID: 1282466
[TBL] [Abstract][Full Text] [Related]
19. Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human alpha1C subunit gene.
Zühlke RD; Bouron A; Soldatov NM; Reuter H
FEBS Lett; 1998 May; 427(2):220-4. PubMed ID: 9607315
[TBL] [Abstract][Full Text] [Related]
20. Molecular diversity of voltage-sensitive calcium channels in smooth muscle cells.
Bielefeldt K
J Lab Clin Med; 1999 May; 133(5):469-77. PubMed ID: 10235130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
